New IVF drug combo aims to boost baby birth rates
NCT ID NCT04064840
First seen May 15, 2026 · Last updated May 15, 2026
Summary
This study tests whether adding a hormone drug (GnRH agonist) to standard IVF treatment can increase the number of live births. It involves 784 women with subfertility. The drug is given as a trigger before egg retrieval and as support after embryo transfer. The goal is to see if this approach works better than current methods.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SUBFERTILITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Department of Obstetrics and Gynaecology
RECRUITINGHong Kong, Hong Kong, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.